BG
Therapeutic Areas
Exosla Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| EV-based Neurorestorative Therapy | Neurological injury in newborn infants | Pre-clinical |
Leadership Team at Exosla Therapeutics
GW
Gareth Willis
Founder and CEO
PA
Pierre Arsène
Founder and Executive Chair
DG
Daniel Gau
Development Lead